Korean J Helicobacter Up Gastrointest Res.
2014 Jun;14(2):82-86. 10.7704/kjhugr.2014.14.2.82.
Medical and Endoscopic Management of Achalasia
- Affiliations
-
- 1Department of Internal Medicine, Soonchunhyang University College of Medicine, Bucheon, Korea. sjhong@schmc.ac.kr
- KMID: 2249454
- DOI: http://doi.org/10.7704/kjhugr.2014.14.2.82
Abstract
- Achalasia is a rare primary esophageal motility disorder. Because its etiology is uncertain, treatment is focused on palliation of symptoms or for decreasing lower esophageal sphincter pressure. Treatment options include pharmacological, endoscopic and surgical methods. Various medications including nitrates, calcium channel blockers, and nitric oxide donors (sildenafil) are available, but their effectiveness is inconsistent. Endoscopic options include pneumatic balloon dilation, injection of botulinum toxin, temporary self-expandable metal stent placement, and peroral endoscopic myotomy. Laparoscopic or open myotomy can be a surgical option. We reviewed the treatment options focusing on medical and endoscopic management of achalasia.
- Full Text Links
-
- Actions
-
Cited
- CITED
-
- Close
- Share
-
- Similar articles
-
- Management of achalasia in 2020: Per-oral endoscopic myotomy, Heller’s or dilatation?
- Management of Achalasia: Expert Consensus Statements
- Case of Concomitant Endoscopic Treatment of Achalasia with Superficial Esophageal Cancer
- Non-achalasia esophageal motility disorders: Role of per-oral endoscopic myotomy
- Role of endoscopy in patients with achalasia
